Calendar Arbutus Biopharma Corporation

Equities

ABUS

CA03879J1003

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 13/06/2025 BST			5-day change	1st Jan Change
3.530 ^USD	-1.40%		+1.44%	+7.95%

05-14	Arbutus Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
05-07	Arbutus Biopharma Corporation Presents Clinical Trial Data from Its Two HBV Assets, Imdusiran and AB-101, At the European Association for the Study of the Liver Congress 2025	CI

Chart calendar Arbutus Biopharma Corporation

26bb96a86f6af630fc8ce1f5.11oids5BSQgnZPFsTfBlYgNklU0EgMDSUG8S7Nb7zfo.vh0TAbp1GDtUDpQGI5MmJDIXpHhB6oXkGl1breTLgbi4aXobkQwAOnc3yQ~f2a5fdfb3b492ea46168f0034c48e8bf

Upcoming events on Arbutus Biopharma Corporation

30/07/2025	Q2 2025 Earnings Release (Projected)
04/11/2025	Q3 2025 Earnings Release (Projected)
25/02/2026	Q4 2025 Earnings Release (Projected)
29/04/2026	Q1 2026 Earnings Release (Projected)

Past events on Arbutus Biopharma Corporation

21/05/2025 15:00	Annual General Meeting
14/05/2025 12:30	Q1 2025 Earnings Release
27/03/2025 11:30	Q4 2024 Earnings Release
03/12/2024 16:00	Investor Meeting - H.C Wainwright
21/11/2024 12:00	Jefferies London Healthcare Conference
15/11/2024 16:00	American Association for the Study of Liver Disease Meeting - Soluble Immune Biomarker Profiling of
15/11/2024 16:00	American Association for the Study of Liver Disease Meeting - HBV Target Site for the RNA Interferen
06/11/2024 13:45	Q3 2024 Earnings Call
06/11/2024 12:30	Q3 2024 Earnings Release
08/10/2024 18:30	H.C. Wainwright Viral Hepatitis Virtual Conference
10/09/2024 13:30	Baird Global Healthcare Conference
09/09/2024 13:00	H.C. Wainwright Global Investment Conference
01/08/2024 13:45	Q2 2024 Earnings Call
01/08/2024 12:30	Q2 2024 Earnings Release
05/06/2024	European Association for the Study of the Liver Congress - Abstract Number : 505
05/06/2024 14:30	Jefferies Global Healthcare Conference
04/06/2024	European Association for the Study of the Liver Congress - Abstract Number : 2389
22/05/2024 15:00	Annual General Meeting
20/05/2024 20:30	H.C. Wainwright BioConnect Investor Conference - Fireside Chat
14/05/2024 14:30	Citizens JMP Life Sciences Conference - Fireside Chat

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026
Net sales Million CAD	Released Forecast Spread	53,1 52,5 1.25%	24,6 28,3 -13.05%	8,80 8,72 0.9%	7,85	6,18
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00
EBIT Million CAD	Released Forecast Spread	-89,1 -85,3 -4.45%	-106 -108 2.15%	-109 -113 3.34%	-59,1	0,00
Earnings before Tax (EBT) Million CAD	Released Forecast Spread	-88,5 -85,5 -3.55%	-98,9 -101 2.23%	-99,7 -103 3.31%	-52,5	0,00
Net income Million CAD	Released Forecast Spread	-94,6 -90,7 -4.27%	-98,9 -99,8 0.86%	-99,7 -103 3.31%	-52,5	0,00
EPS CAD	Released Forecast Spread	-0,63 -0,61 -2.9%	-0,60 -0,61 1.69%	-0,54 -0,55 1.05%	-0,37	-0,34
Announcement Date		02/03/23	29/02/24	27/03/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million CAD	Released Forecast Spread	6,37 6,41 -0.54%	2,91 6,51 -55.28%	2,11 3,68 -42.75%	2,39 2,42 -1.06%	1,86 2,57 -27.91%	2,25 2,21 1.69%	2,46 2,29 7.78%	2,22	2,19	1,00	1,86	1,86	1,86	1,79
EBIT Million CAD	Released Forecast Spread	-29,5 -28,0 -5.14%	-28,2 -30,1 6.48%	-26,6 -27,7 3.95%	-29,9 -26,8 -11.57%	-29,7 -27,3 -8.93%	-19,9 -24,6 19.08%	-35,9 -27,3 -31.34%	-8,24	-7,68	-7,12
Earnings before Tax (EBT) Million CAD	Released Forecast Spread	-27,5 -26,9 -2.13%	-26,2 -28,2 6.88%	-24,6 -25,8 4.7%	-27,4 -24,7 -10.89%	-27,3 -24,8 -10.3%	-17,9 -22,1 19.24%	-34,3 -25,3 -35.42%	-6,71	-6,15	-5,59
Net income Million CAD	Released Forecast Spread	-27,5 -26,9 -2.13%	-26,2 -28,2 6.88%	-24,6 -25,8 4.7%	-27,4 -24,7 -10.97%	-27,3 -24,8 -10.26%	-17,9 -22,1 19.24%	-34,3 -25,3 -35.42%	-6,71	-6,15	-5,59
EPS CAD	Released Forecast Spread	-0,16 -0,15 -6.56%	-0,16 -0,16 -1.19%	-0,14 -0,15 7.81%	-0,15 -0,13 -15.73%	-0,14 -0,13 -6.91%	-0,10 -0,11 11.48%	-0,18 -0,15 -22.23%	-0,07	-0,06	-0,06	-0,08	-0,08	-0,08	-0,08
Announcement Date		07/11/23	29/02/24	02/05/24	01/08/24	06/11/24	27/03/25	14/05/25	-	-	-	-	-	-	-

Upcoming sector events for Arbutus Biopharma Corporation

15/06/2025	MIRAI CORPORATION: Q2 2025 Earnings Release
15/06/2025	AÉROPORTS DE PARIS: May 2025 Sales and Revenue Release - Traffic Figures
15/06/2025	LENNAR CORPORATION: Q2 2025 Earnings Release
15/06/2025	RENEW ENERGY GLOBAL PLC: Q4 2025 Earnings Release
15/06/2025	PARK24 CO., LTD.: Q2 2025 Earnings Release
15/06/2025	POWERFLEET INC.: Q4 2025 Earnings Release
15/06/2025	NTT UD REIT INVESTMENT CORPORATION: Q2 2025 Earnings Release
15/06/2025	CAFÉ DE CORAL HOLDINGS LIMITED: Q4 2025 Earnings Release
15/06/2025	ICHIGO OFFICE REIT INVESTMENT CORPORATION: Q2 2025 Earnings Release
16/06/2025 07:00	NEXTENERGY SOLAR FUND LIMITED: Q4 2025 Earnings Release

More events

Past sector events for Arbutus Biopharma Corporation

13/06/2025 22:22	FREEDOM HOLDING CORP.: Q4 2025 Earnings Release
13/06/2025 13:45	CHARLES SCHWAB: May 2025 Sales and Revenue Release - Activities Report
13/06/2025 12:02	UTILICO EMERGING MARKETS TRUST PLC: Q4 2025 Earnings Release
13/06/2025 07:00	OXFORD INSTRUMENTS PLC: Q4 2025 Earnings Release
13/06/2025 07:00	AVI GLOBAL TRUST PLC: Q2 2025 Earnings Release
13/06/2025 06:00	FRAPORT AG: May 2025 Sales and Revenue Release - Traffic Figures
12/06/2025	ASTROSCALE HOLDINGS INC.: Q4 2024 Earnings Release
12/06/2025	KURA SUSHI,INC.: Q2 2025 Earnings Release
12/06/2025	H.I.S. CO., LTD.: Q2 2025 Earnings Release
12/06/2025	J.S.B.CO.,LTD.: Q2 2025 Earnings Release